The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PARTNER: A randomized, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in patients with triple-negative and/or germline BRCA-mutated breast cancer.
 
Lynsey Drewett
No Relationships to Disclose
 
Rebecca Lucey
Consulting or Advisory Role - AstraZeneca
Expert Testimony - Eisai Europe; Pfizer/EMD Serono
 
Karen Andrea Pinilla
Stock and Other Ownership Interests - Illumina (I)
 
Louise Grybowicz
No Relationships to Disclose
 
Jerome Wulff
No Relationships to Disclose
 
Alimu Dayimu
No Relationships to Disclose
 
Nikos Demiris
No Relationships to Disclose
 
Anne-Laure Vallier
No Relationships to Disclose
 
Wendi Qian
No Relationships to Disclose
 
Andrea Machin
No Relationships to Disclose
 
Karen McAdam
Consulting or Advisory Role - AstraZeneca; Eisai; Seagen
 
Rebecca Roylance
Leadership - Google health (I)
Honoraria - Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca
Consulting or Advisory Role - Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Iqvia; Lilly
Travel, Accommodations, Expenses - BMS; Daiichi Sankyo Europe GmbH; Daiichi Sankyo Europe GmbH; Roche/Genentech
 
Ellen Copson
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; NanoString Technologies; NanoString Technologies; Pfizer; Roche; Sanofi/Aventis
Speakers' Bureau - AstraZeneca; AstraZeneca; Pfizer; Pfizer; Roche; Sanofi/Aventis
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); SECA
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Anne C. Armstrong
Stock and Other Ownership Interests - AstraZeneca (I)
Consulting or Advisory Role - Gilead Sciences; MSD
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; MSD Oncology
 
Nicola Levitt
Stock and Other Ownership Interests - AstraZeneca
Honoraria - Eisai; Genomic Health/Exact Sciences; Lilly; Novartis; Pfizer; Roche
 
Elena Provenzano
No Relationships to Disclose
 
Marc D. Tischkowitz
No Relationships to Disclose
 
Emma McMurtry
Consulting or Advisory Role - AstraZeneca
 
Helena Margaret Earl
Honoraria - Intas
Travel, Accommodations, Expenses - Intas
 
Jean Abraham
Research Funding - AstraZeneca/MedImmune